Product Code: CHIS
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 and other ailments maintain value sales
Teva Pharmaceutical Industries continues to lead and private label continues to gain share
E-commerce continues to gain value share
PROSPECTS AND OPPORTUNITIES
Social behaviour changed by COVID-19
Analgesics innovate through further segmentation
New chemists/pharmacies retail outlets likely to stimulate price competition and growth
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Recovery begins as society opens up
Teva Pharmaceutical Industries continues to lead and private label gains share
Consumers look for natural, home-made remedies
PROSPECTS AND OPPORTUNITIES
Normalisation of public life maintains value sales
Immune-boosting properties remain popular
Antihistamines/allergy remedies see further growth
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Digestive remedies recover as eating out leads to more unhealthy eating
GSK Consumer Healthcare faces increasing competition from medical devices, prescription medication, and lifestyle changes
Conflicting trends at play in digestive remedies
PROSPECTS AND OPPORTUNITIES
Healthier eating could dampen growth rates over forecast period
Private label and e-commerce gain value share over forecast period
Developments in herbal products will lead the way for health-conscious consumers
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Opening of schools leads to boost in value sales for lice treatments
Perrigo Israel Pharmaceuticals maintains its lead
Hair loss treatments benefits from pandemic
PROSPECTS AND OPPORTUNITIES
Moderate growth over the forecast period
Private label fight to gain value share
Social stigma of certain products benefits online sales
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
More people try to give up smoking as smokers are more severely affected by COVID-19
Nicotinell - virtually the only brand present
Alternative therapies for giving up smoking gaining traction
PROSPECTS AND OPPORTUNITIES
Shrinking user base set to limit growth
Stamp down on e-vapour products boosts value sales
Little innovation expected
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Heightened anxiety due to pandemic continues to boost value sales for sleep aids
Neopharm Import (Israel) 1966 continues to lead but faces increasing competition
Consumers look for natural ingredients
PROSPECTS AND OPPORTUNITIES
Greater acceptance of sleep aids leads to value growth
Players continue to innovate
E-commerce big winner from pandemic
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Strong performance as extended times spent on screens leads to strained eyes
Lapidot Medical Import and Marketing extends its lead
Shift to higher-priced products
PROSPECTS AND OPPORTUNITIES
Outlook very positive over forecast period
Allergy eye care is expected to see high growth due to climate change
Natural positioning key part of messaging
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Recovery after 2020 slump
Chemipal extends its lead but strong growth for private label threatens its position
Growing variety of printed plasters
PROSPECTS AND OPPORTUNITIES
Recovery picks up as society reopens
Private label gains value share
Innovation needed to stand out from competition
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Lower value growth than 2020, but still healthy
Ta'am Teva-Altman General Partnership maintains its lead and Ambrosia Ltd Solgar Israel loses share
E-commerce boosted by the pandemic
PROSPECTS AND OPPORTUNITIES
Healthy value growth
Increasing segmentation over forecast period
Innovation in formats over forecast period
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Healthy value growth but lower than 2020
Ta'am Teva-Altman General Partnership maintains its lead, while Ambrosia Ltd Solgar Israel remains in second place despite losing share
E-commerce boosted by the pandemic
PROSPECTS AND OPPORTUNITIES
Moderate outlook over forecast period
Holistic approach to health drives value sales
More targeted solutions over forecast period
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Value growth static as consumers increasingly shun crash diet products
Herbalife International of Israel (1990) continues to lead, while Oriental Secrets loses share due to the dramatic declines in slimming teas
Supplement nutrition drinks registers positive value growth
PROSPECTS AND OPPORTUNITIES
Bleak outlook for weight loss products
E-commerce continues to grow at healthy pace
Slimming teas lose further ground
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sports nutrition recovers as society opens up
Meditrend continues to lead in 2021
E-commerce hugely benefits from lockdowns
PROSPECTS AND OPPORTUNITIES
Rosy outlook over forecast period
Protein enters the mainstream
Growth supported by dietary trends
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sleeps aids best performer due to anxiety around COVID-19
Ta'am Teva-Altman General Partnership retains its lead and private label extends its share in 2021
A holistic approach to health contributes to growth
PROSPECTS AND OPPORTUNITIES
Healthy value growth over forecast period
Online space key battleground over forecast period
Paediatric products grow strongly over forecast period
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN ISRAEL
KEY DATA FINDINGS
2021 DEVELOPMENTS
With schools open, common cold spreads again leading to increased value sales of cough/cold remedies
Teva Pharmaceutical Industries maintains its lead and Ta'am Teva-Altman General Partnership retains its second place, while private label increases its share in 2020
Players focus on child-friendly design
PROSPECTS AND OPPORTUNITIES
Demographic trends to dominate with normalisation
Shift towards natural products over forecast period
Hectic lifestyles expected to encourage parents to provide paediatric vitamins and dietary supplements to their children
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
